Yair Erez, M.D.

https://lnkd.in/dAJMeYx3 Our portfolio company Seegnal initiates business in the UK. Seegnal is a smart and intuitive clinical decision support platform that empowers clinicians to quickly & effectively manage and resolve patient-specific Drug Related Problems (DRPs). Seegnal’s unique approach shows a reduction of up to 94% in Alert load, while achieving a 98% alert accuracy as a result of its patient-tailored alert algorithms and single screen graphic interface. Seegnals interfaces with the Electronic Medical Record (EMR) or any other relevant platform and incorporates the widest scope of relevant patient data into an intuitive, all-in-one, patented interface. Eyal Schneid Dr. Shiri Guy Alfandary, PharmD. Jack Steckel Oded Orgil 🎗️

5

1 Comment

The Economist highlights productivity as a pressing problem within the UK National Health Service, just as it is the case in other countries. I'm proud that the AI-backed data platform of DEO.care, succeeds time and time again to increase surgery volume in #hospitals and #ASC's in both Europe and the US while at the same time reducing the fatigue of the surgical teams involved. That way we can help keeping #healthcare viable. #medtech #digitaltwin

24

The role of AI and new technology to aid cardiology “As cardiology starts to face staffing shortages and continued decreases in CMS payments, Biga believes technology advances need to be leveraged in cardiology to help improve outcomes, make workflows more efficient to do more with less, and to help cut costs.” “Many of the solutions that can help were displayed on the expo floor, including telehealth and real-time remote monitoring systems. "I think this area will experience an explosion in use," Biga said. Another major area that will likely see an explosion of use is artificial intelligence (AI). She said AI will begin playing a rapidly growing role in cardiology in the coming years to augment cardiologists and other clinical staff. And not just on the front lines of patient care, but also in the back offices where AI will play a growing role in IT systems, smoothing workflow, analytics, automated quality metrics capture and many other areas. "We must use AI to reduce administrative burdens and improve patient outcomes," Biga explained. “

17

1 Comment

Insights from the "Pharma & Medtech – Partnering with Entrepreneurs" panel at Tech Tour's Mental and Brain Health Event The pharma business follows a product lifecycle logic and startups have a role to play all along that lifecycle from discovery, to conception, to development, to evidence-generation, to regulatory to commercialisation. The trick to working with Eisai Co., Ltd. is to find a match in the two main areas in which we operate: oncology and neurology. (who would have thought so?) "At Roche digital health products are very welcome, but not as a business per se. They can enhance and support the existing business." Advice to startups: - a new product launch costs 4-5 bn on average - anything that can increase scientific confidence that your molecule is on the right track - anything that helps to speed things up, reduce cost or increase precision - anything that increases bureaucracy in a clinical trial or in daily practice, will not see adoption. - co-create whatever you do with patients Pharma is a highly regulated industry. Regulators act as air traffic controllers as well as police. The trick is to engage with them as air traffic controllers, not as police. There is a big gap to bridge: Pharma build something once over a long period of time and it stays that way. Digital startups move fast bring something to market and make many iterative improvements over time. Be clear about what it is you are trying to do. Try to be as precise as possible. Less is more. In pharma you typically have one person that is triaging opportunities. Try to make their life as simple as possible. Your solution has to meet the operational requirements of pharma companies. Don't go to pharma companies with your investor pitch. Think about what problem you can solve for them! If you just need money to keep going that's not a partnership. Talk to their venture arm, not their innovation arm. Insights from Naomi Fried, Ph.D., Paul Ashley, Ricardo Sáinz Fuertes LMS MSc MRCPsych PhD, Jan Schadrack

21

4 Comments

Thrilled about our next episode where we highlight the advent of digital transformation in healthcare through robotics. The new era of healthcare experiencing it through the insights and experiences of Dr Sivaprakasam Rajesh Sivaprakasam. #healthcare #lalithasdna #robotics #digitalhealth

8

Digital Health Unplugged Podcast: Why is the NHS so difficult to sell to? https://lnkd.in/emEnAtY6 Jordan Sollof, reporter at Digital Health News, is joined by Lloyd Price and Mohammad Al-Ubaydli to talk about procurement and why the NHS is so difficult to sell to. From their own experience, Price, a HealthTech founder, M&A advisor for Nelson Advisors and Non-Executive Director for various Digital Health companies, and Al-Ubaydli, Founder and Chief Executive of Digital Health social enterprise, Patients Know Best, shine a light on the main issues that can make selling to the NHS a challenge. The pair discuss success stories of startups which have successfully sold to the NHS, before assessing whether companies and suppliers need to take more care in ensuring they are pitching the right solution to the right organisation. They give their views on whether the NHS procurement process has become overcomplicated, a point raised in a session at Rewired 2024, and speculate whether the forthcoming Procurement Act (which was originally due to come into force in October 2024, but has been delayed until February 2025) will solve some issues and make it easier for those selling in the health technology sector. Finally, the guests predict what they anticipate will happen in the coming months and years, including whether the NHS will become a simpler system as a whole to sell to or if we will still be having the same conversation about difficulties selling in a few years’ time https://lnkd.in/emEnAtY6

14

4 Comments

Medical Record Automation: MRA emerges as one of the key HealthTech sub sectors in 2024 https://lnkd.in/e4GKYsxW Medical Record Automation is the process of using technology to streamline and optimise the management of patient health information. It involves the digitalisation, storage, retrieval, and analysis of medical records to improve efficiency, accuracy, and accessibility. Medical Record Automation (MRA) has undeniably emerged as a critical subsector within HealthTech in 2024. It's driven by a perfect storm of factors: Increasing data volumes: The sheer amount of patient data generated daily is overwhelming. Demand for efficiency: Healthcare providers are under immense pressure to reduce costs and improve patient care. Data privacy concerns: Securely handling sensitive patient information is paramount Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' to maximise shareholder value.   HealthTech Mergers, Acquisitions, Growth & Strategy > www.nelsonadvisors.co.uk   Nelson Advisors HealthTech M&A Newsletter > Subscribe Today! https://lnkd.in/e5hTp_xb   Buy Side, Sell Side, Go To Market, Partnership Strategies > Email [email protected]   Nelson Advisors HealthTech Thought Leadership > Visit https://lnkd.in/ezyUh5i   #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #Partnerships #VentureCapital #PrivateEquity https://lnkd.in/e4GKYsxW

7

1 Comment

The UK's delicate industrial strategy balancing act: our service industry must embrace GenAI, but the risk is that we hand our future to US BigTech. My article in Bright Blue's new collection of essays on the impact of Generative AI, alongside such luminaries as Kenneth Cukier Rose Luckin Gerard Grech Tom Watson. "It is easy to be cynical about endless promises surrounding the transformative potential of AI. However, even if the current break-neck pace of technological development were to slow down, we are already seeing the first stirrings of a productivity revolution, especially in the services industry. This matters because the UK is the second-biggest exporter of services in the world, and, at present, we face a conundrum. If we do not embrace the AI opportunity, then we risk falling behind and losing our competitive edge. But, if we do fully embrace AI, we risk handing the keys to our economy over to the US tech giants on whose AI platforms our technological future depends." Let's hope that the next Government has the bandwidth and vision to focus on both aspects of this challenge. Do check out pages 38-39 (as well as all the other great articles obviously) for the Best Practice AI view on this. With thanks to Sarah Kuszynski and Ryan Shorthouse. https://lnkd.in/g8CJtAkJ

26

4 Comments

At Medable, Inc we do not build better versions of things that already exist, we create categories. Come check out the future of evidence generation, Medable Studio, where your teams take control to seamlessly launch complex DCT and eCOA solutions, globally. You will see the fruits of innovation - the hard lessons and tough wins, turned into transformative technology. Our industry has never seen a solution like Medable Studio before. At Medable, we innovate because patients need a future created by innovation, not iteration.

61

1 Comment

🎙️Buckle up for another electrifying episode of The Healthcare Landscape Podcast! This week, I'm joined by a budding star in the realm of #HealthTech - Felix Geilert - Chief Technology Officer of Munich-based Radiant Science. With a background that spans #DataScience and #MachineLearning at #Microsoft and #Meta, Felix is part of the revolution in #Healthcare. At Radiant Science, he's pioneering the charge with in #PreventiveCare and #Medicine3.0 initiatives, leveraging cutting-edge #AI and #LargeLanguageModels. In this episode, we dive deep into the imperative for #QualityCare and the urgent need for #InnovationInHealthcare. We look into how Radiant Science is harnessing the power of #DataScience to #PersonalizeCare, in order to enhance the #PatientExperience, and make healthcare #EfficientAndAccessible for all. We also discuss the challenges of the ever-evolving #HealthcareLandscape in the context of the US and Europe. Tune in, share your thoughts: Ai/ML in prevention https://lnkd.in/e3gTUFJu #HealthcareInnovation #TechInMedicine #ArtificialIntelligence #StreamlineOperations #HealthcareRegulations

21

2 Comments

Digital therapeutics (Dtx) have the potential to revolutionize the healthcare system. The UK is leading the way in demonstrating the effectiveness of Dtx for obesity while all the buzz these days, is around pharmaceutical solutions. As someone who has been in the Dtx space for two years, I can only attest to the potential of digital therapeutics. #Digital #Therapeutics #Obesity #UK

13

Written by esteemed investor Bill Gurley, this piece on opportunities in healthcare where patients (should) come first is a fascinating read. Written in 2017, the article has withstood the test of time — mainly because so few in healthcare have focused on D2C, founders and investors alike. With AI, texting, video calls, and other technologies readily available, the opportunity to create a giant patient-centric healthcare system has never been greater. It’s time to build something for the people.

31

4 Comments

Who doesn't love these strategy maps from CB Insights? We need to bring these maps into the Kidneyverse to better understand the strategies of kidney care market movers including: 🏪 retailers 🏥 providers 💰 payers 💊 pharma 💉 manufacturers ⚙ VBC / enablers 🤖 tech companies Here are a few perspectives I think this exercise will help us better understand heading into the second half of 2024 and beyond: 1. How retailers think about primary care 2. How primary thinks about polychronic care 3. How polychronic thinks about value-based care 4. How VBC thinks about payer growth 5. How payers think about provider growth 6. How providers think about tech / services 7. How services companies think about tech 8. How tech thinks about pharma partners 9. How pharma thinks about tech / pipeline 10. ??? Within each of these perspectives we find groups of key players, many millions of impacted lives, and many billions of invested capital. This type of deep dive into a single company strategy is important. So far in our Kidney Capital series we've spent a lot of time talking about the most active invest-ors in the space (see link in comments). Now it's time to talk about invest-ments. Let's see how these companies put their money to work. Which of these are you most interested in? Which other stakeholders or POVs should we include? Leave a comment and let us know.👇🏼 #health #tech #innovation #startups #healthtech

42

5 Comments

⚠️ Ignore Interoperability at Your Own Risk Building a health tech product that doesn’t integrate with existing systems? Big mistake. Here’s why: 🔗 Healthcare providers want solutions that fit into their current workflows, not disrupt them. 🌍 In markets like the NHS, integration isn’t optional - it’s essential. Startups that focus on seamless interoperability will: Speed up adoption. Gain the trust of providers. Set themselves up for long-term success. 💡 Don’t build a silo. Build for the ecosystem. #Healthtech #Interoperability #NHS #EHRIntegration #Health #Innovation

17

1 Comment

3 noteworthy acquisitions were announced in #DigitalHealth last week, moving the total to 76 acquisitions in 2024 till date. - On Tuesday, Switzerland-based Mediktor announced the acquisition of Sensely, a San Francisco-based digital healthcare provider that pioneered an empathy-driven conversation platform to support hospital systems and insurance services with world-class member engagement. - On Thursday, Carevīve was acquired by Health Catalyst. The acquisition strengthens Health Catalyst's position in the digital healthcare market, expanding its capabilities in patient engagement and care coordination. - On Friday, Doktor.se announced that it acquired competitor Doktor24. The combined entity will provide a comprehensive suite of digital healthcare services, including telemedicine consultations, patient engagement platforms, and data analytics capabilities. Compared to last year, the total number of acquisitions is still trending significantly lower. Till date, the M&A activity in Digital Health has been 14% lower as compared to the same period last year. #Merger #Acquisitions #healthcarefinancing Source: All data from Alpha Edge, the business intelligence tool in HealthTech Alpha

18

1 Comment

there's so much you can think of whilst you're holding the surgeon's consultant forceps, scissors or retractor. innovation needs to start from the ground up and healthcare ecosystems need to nurture intrapreneurship within their folds. Team Consulting highlighted 6 challenges in the operating room but the list is never ending. from the moment the patient agrees to have the operation, to the pre-op and post-op rooms. read more 👇

13

"Why have you chosen to pivot into healthcare?" One of the greatest privileges I enjoy in Adopt-A-Doc is the opportunity to speak to a wide range of healthtech #founders. To note, over 90% of these founders come from a technical or commercial background - rather than clinical. One of the first questions that I always ask is: 𝐖𝐡𝐲 𝐡𝐚𝐯𝐞 𝐲𝐨𝐮 𝐜𝐡𝐨𝐬𝐞𝐧 𝐭𝐨 𝐞𝐧𝐭𝐞𝐫 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐨𝐟 𝐚𝐥𝐥 𝐟𝐢𝐞𝐥𝐝𝐬? Now bear in mind, many of these founders have actually left jobs that were: - In stable industries, - Very well compensated, - In larger, multinational corporations, 👉 To foray in healthcare which has its own sets of challenges. _______________________________ I have heard many great stories. They range from: - A personal or family experience with illness, and the deep dissatisfaction that came from it. - A desire to make things better having seen first hand how prevalent ill health is. - A strong motivation to use their skill set to build something impactful. 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐢𝐬 𝐢𝐧𝐝𝐞𝐞𝐝 𝐚𝐧 𝐚𝐫𝐞𝐚 𝐰𝐡𝐞𝐫𝐞 𝐭𝐡𝐞 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐭𝐨 𝐝𝐨 𝐠𝐨𝐨𝐝 𝐢𝐬 𝐢𝐦𝐦𝐞𝐧𝐬𝐞.  A successful #innovation scaled widely can help thousands, if not millions of people. _____________________________ I believe that #healthcare attracts people who are trying to help. It is the one reason why I am still hopeful about healthcare. Because there are brilliant innovators from all walks of life coming together to work on this important problem. 𝐈𝐬 𝐢𝐭 𝐥𝐢𝐤𝐞𝐥𝐲 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐡𝐞𝐚𝐥𝐭𝐡 𝐬𝐲𝐬𝐭𝐞𝐦 𝐰𝐢𝐥𝐥 𝐬𝐨𝐥𝐯𝐞 𝐢𝐭𝐬 𝐨𝐰𝐧 𝐩𝐫𝐨𝐛𝐥𝐞𝐦𝐬 𝐟𝐫𝐨𝐦 𝐰𝐢𝐭𝐡𝐢𝐧? Probably not, because if so, we would have already done it. 𝐂𝐚𝐧 𝐭𝐡𝐞 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐛𝐞 𝐟𝐢𝐱𝐞𝐝 𝐬𝐨𝐥𝐞𝐥𝐲 𝐛𝐲 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐨𝐫𝐬 𝐨𝐮𝐭𝐬𝐢𝐝𝐞 𝐨𝐟 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞? Also unlikely, because healthcare is genuinely complex and care delivery is heavily reliant on healthcare professionals. 𝐈𝐭 𝐢𝐬 𝐰𝐡𝐲 𝐰𝐞 𝐡𝐚𝐯𝐞 𝐭𝐨 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐞. 🤝 ______________________________ Healthcare Innovation is ultimately a team sport. And I am happy to be able to help founders tackle this behemoth, to the best of my abilities. 😊 A Friday toast to the people working hard to make healthcare better. 🍷 Dora Jambor | Ishtar Govia | Craig Coulton | Nikos Ioannou | Ben Davies | Claire Brannigan | Nara Moripen | Thibaut Briere | Ula Rustamova

60

24 Comments

How patient-centric is the pharma industry? 🤔 This question lingered at last week's Patient Centricity and Engagement conference in London. The alignment between patient advocates and industry voices on patient involvement was powerful, but the conversations revealed we’ve got work to do to get to where we want to go. Key insights I’m taking back to Stitch: 📈 ROI drives action: Patient engagement must show clear value. 💯 All-in commitment: It’s everyone’s job, not just one department’s. 🏥 Direct support matters: The industry drives value with toolkits and support for sites and patients. Thanks to the organisers for a great event. Looking forward to next year 

71

1 Comment

🚀 The Future of UK HealthTech: The ABHI's new manifesto offers a dynamic vision for advancing UK healthcare through technology. Here’s what’s on the agenda: 🔹 Industry at a Glance: With 154,000 employees and a £34bn turnover, HealthTech is pivotal to the UK's life sciences sector. Yet, facing challenges like regulatory uncertainties and slow NHS adoption, it’s time for a strategic overhaul. 🔹 10-Point Plan Highlights: ➡️ Regulatory Excellence: Create a world-class regulatory environment that accelerates innovation and patient safety. ➡️ Innovative Procurement: Reform NHS procurement to foster quick adoption of HealthTech solutions. ➡️ Investment in Infrastructure: Expand physical and digital infrastructure to support advanced manufacturing and data-driven health solutions. ➡️ Global Leadership: Enhance UK HealthTech’s global export potential through targeted support and international collaboration. 🔹 Government Collaboration: To actualise these goals, ABHI recommends appointing a HealthTech Champion to advocate for the industry’s nuanced needs, driving forward both economic growth and healthcare improvements. 🌍 By implementing these transformative strategies, the UK can lead in delivering efficient, patient-centric healthcare globally. 🔗 https://lnkd.in/eP-6NwjH #HealthTech #UKHealthcare #Innovation #DigitalTransformation #NHS Eleanor Charsley Paul Benton Lottie McMahon Michelle Michelucci Richard Devereaux Phillips

33

1 Comment